Epoprostenol

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14451 publications

Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series.

Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series.

Journal: The journal of vascular access

Published: June 24, 2026

A profile on inhaled treprostinil for pulmonary hypertension.

A profile on inhaled treprostinil for pulmonary hypertension.

Journal: Expert review of respiratory medicine

Published: June 23, 2026

Pulmonary Hypertension and Kidney Disease: A Review of a High-Risk Patient Population.

Pulmonary Hypertension and Kidney Disease: A Review of a High-Risk Patient Population.

Journal: Cardiology in review

Published: June 23, 2026

Clinical and functional characteristics of patients with interstitial lung disease and pulmonary hypertension from a specialized lung disease center in Buenos Aires

Clinical and functional characteristics of patients with interstitial lung disease and pulmonary hypertension from a specialized lung disease center in Buenos Aires

Journal: Medicina

Published: June 22, 2026

Recurrent Seizure-Like Events in a Toddler With BMPR2-Related Pulmonary Arterial Hypertension.

Recurrent Seizure-Like Events in a Toddler With BMPR2-Related Pulmonary Arterial Hypertension.

Journal: Ochsner journal

Published: June 18, 2026

Antithrombin and 20% albumin as treatment of oxygenator high pressures excursion during cardiopulmonary bypass in cardiac surgery: A case report.

Antithrombin and 20% albumin as treatment of oxygenator high pressures excursion during cardiopulmonary bypass in cardiac surgery: A case report.

Journal: The International journal of artificial organs

Published: June 17, 2026

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis.

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis.

Journal: Hospital pharmacy

Published: May 22, 2026

Treatment strategies for pulmonary arterial hypertension associated with adult congenital heart diseases.

Treatment strategies for pulmonary arterial hypertension associated with adult congenital heart diseases.

Journal: Expert review of clinical pharmacology

Published: May 20, 2026

Progress in targeted therapy for chronic thromboembolic pulmonary hypertension

Progress in targeted therapy for chronic thromboembolic pulmonary hypertension

Journal: Zhonghua yi xue za zhi

Published: May 14, 2026

Optimizing platelet secretome production: Impact of prostaglandin I₂ during platelet isolation on platelet activation and secretome molecular composition.

Optimizing platelet secretome production: Impact of prostaglandin I₂ during platelet isolation on platelet activation and secretome molecular composition.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: April 28, 2026

3D Printing and Electrospinning of PLLA-co-CL/PDLA Blends as Potential Materials for Cardiovascular Implants.

3D Printing and Electrospinning of PLLA-co-CL/PDLA Blends as Potential Materials for Cardiovascular Implants.

Journal: ACS biomaterials science & engineering

Published: April 28, 2026

Sustained CREB Phosphorylation Is Associated with Neuritogenic Prostanoid Signaling in NSC-34 Cells.

Sustained CREB Phosphorylation Is Associated with Neuritogenic Prostanoid Signaling in NSC-34 Cells.

Journal: Cells

Published: April 26, 2026

Showing 1-12 of 14,451

Last Updated: 06/30/2026